Exploration of Lipid Mediators for Therapeutic Monitoring of Pancreatic Cancer Patients
PDAC patients with initially low LPC levels in the blood exosomes demonstrated an unfavorable PFS. Exosomal lipid markers may serve as potential indicators for disease monitoring in pancreatic cancer patients undergoing multimodal treatment.
Authors
- Fuminori Sonohara (ORCID: https://orcid.org/0000-0001-6438-2122)
- Norifumi Hattori (ORCID: https://orcid.org/0000-0002-1433-7208)
- Nobuhiko Nakagawa (ORCID: https://orcid.org/0000-0003-2095-1308)
- Chie Tanaka (ORCID: https://orcid.org/0000-0002-0829-7342)
- YASUHIRO KODERA
- Haruyoshi Tanaka (ORCID: https://orcid.org/0000-0003-0079-8422)
- TOMOHISA OTSU
- Yoshikuni Inokawa (ORCID: https://orcid.org/0000-0002-1412-1124)
- MITSURO KANDA
- Hideki Takami
- Masamichi Hayashi (ORCID: https://orcid.org/0000-0001-6875-2303)
- Keisuke Kurimoto
- Daigo Kobayashi
- Goro Nakayama
Institutions
- Nagoya University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-03-28
- DOI
- https://doi.org/10.21873/anticanres.17520
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00